Skip to content

Almax Pharma

Active Private limited companyfounded 2014active for 12 yearsRue Saint Pierre et Paul 10, 5651 WalcourtKBO/BCE: BE 0556.705.368

Lifetime

10 annual accounts with figures on one time axis
peak of €116,379 in 2016
€29,811▼ 10.1%
peak of €70,520 in 2016
€2,070▼ 88.2%
peak of €303,429 in 2025
€303,429▲ 0.7%
€43,227▼ 29.7%
Board1 name since 2014
1 director
Documentsfilings and deeds
04-11-20254 days late
2025micro format
Result from €17,547 to €2,070Debts from €61,448 to €43,227Cash from €219 to €1,467

Key points

from the 2025 annual accounts

Equity

€303,429 ▲ 0.7%

Almax Pharma has made a profit in every financial year since 2016.

Filings

10 annual accounts 22 days past the deadline
deadline20202025

2026 accounts not filed: deadline was 31-10-2026.

Position in the sector

87.5%

Higher solvency than 92% of companies in retail trade. The sector median is 33.2%, over 25,459 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 10,923 companies had the same profile as Almax Pharma has now. Each dot stands for 28 companies, two years later.

95.0%
were still trading
4.2%
stopped another way
0.8%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 10,923 companies, not a prediction for Almax Pharma. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 17-07-2014
  • founderdeed of 22-07-2014
  • founderdeed of 22-07-2014
  • founderdeed of 22-07-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0556705368
changes role from manager to director Discharge granted to · Gazette deed
Incorporation Founding capital of €18,600, 1,000 shares, €6,200 paid up · Founded by (constituante), (constituant) and (constituante) · appointed as manager · published on 22-07-2014 · Gazette deed
First establishment Rue Saint Pierre et Paul 10, Walcourt
All 18 events

Comparable companies

same main activity, similar in size and age
Company
Almax Pharma Walcourt €346,656 €29,811 87.5% -
AP'ART Ghent €322,780 €30,457 55.8% -
Pharmacie du Parc Astrid Anderlecht €342,276 €25,742 68.8% -
TANNHAUSER PHARAESCOS Koekelberg €292,153 €30,406 46.9% 0
PHARMACIE DEMARS Mettet €365,428 €21,493 31.6% -
Apotheek Jacobs Lokeren €307,849 €33,846 90.8% -
ASKELA Chièvres €293,294 €25,341 99.5% -

These companies have the same main activity as Almax Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €292,000 and €365,000, founded between 2010 and 2016.

Official details

Source: KBO
Status
Active since 17-07-2014Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.233.754.3055651 Walcourt, since 17-07-2014
Financial year end
31 March
Peppol
Reachable since 20-01-2026
Company details

Annual accounts to 31-03-2025

≈ €140,000estimated
€346,656▼ 4.5%
Filing
Filed on 04-11-2025
Financials

Insights on Almax Pharma

Almax Pharma files the micro format. That format states no turnover. The gross margin fell from €116,379 in 2016 to €29,811 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Almax Pharma

What is the company number of Almax Pharma?
The company number of Almax Pharma is 0556.705.368. The VAT number is the same number with BE in front: BE 0556.705.368.
Where is Almax Pharma based?
The registered office is at Rue Saint Pierre et Paul 10, 5651 Walcourt.Company details
What does Almax Pharma do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Almax Pharma?
Almax Pharma is a private limited company (BV).
When was Almax Pharma founded?
Almax Pharma was founded on 17-07-2014.
Is Almax Pharma still active?
Yes, Almax Pharma is an active enterprise in the KBO register.
What is the turnover of Almax Pharma?
The turnover in financial year 2025 is about €140,000. This figure is estimated from the gross margin of €29,811 and 56 comparable companies (NACE 477). It probably lies between €75,000 and €240,000.Financials
Is Almax Pharma profitable?
In financial year 2025, Almax Pharma made a profit of €2,070.
Where can I find the annual accounts of Almax Pharma?
Almax Pharma filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Almax Pharma due?
Almax Pharma had to file the annual accounts for financial year 2026 by 31-10-2026.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.